BioRestorative Therapies Inc.
BRTX | NASDAQ
$2.55
-$0.16 (-5.90%)
Sep 22, 2026, 1:01 PM ET · Market open
TTM Period Ending | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -11.06M | -14.24M | -12.67M | -10.72M | -12.1M | -8.98M | -6.17M | -310.99K | -1.99M | -6.94M | -12.46M | -21.89M | -20.85M | -18.49M | -34.55M | -34.08M | -33.47M | -44.3M | -29.66M | -26.31M | -19.38M |
Depreciation & Amortization | 210.6K | 209.99K | 207.52K | 203.17K | 198.12K | 189.06K | 181.4K | 175.28K | 169.1K | 165.74K | 154.82K | 143.9K | 133.89K | 120.55K | 139.31K | 129.66K | 173.17K | 176.19K | 151.1K | 154.99K | 106.66K |
Stock-Based Compensation | 1.61M | 3.33M | 3.05M | 2.94M | 2.79M | 2.81M | 2.64M | 3.81M | 4.97M | 6.32M | 9.38M | 11M | 12.62M | 12.61M | 9.55M | 9.41M | 6.3M | 2.93M | 2.99M | 250.56K | 469.82K |
Other Working Capital | 518.09K | 297.05K | -87.72K | -36.99K | 94.54K | -95.93K | 20.8K | 90.11K | -1.72K | 500.14K | 286.31K | 30.33K | 16.89K | -94.93K | -174.14K | 34.6K | 78.38K | 380.71K | 89.45K | -98.57K | 612.76K |
Other Non-Cash Items | -3.15M | -1.39M | -1.81M | -2.31M | -60.01K | -2.28M | -4.37M | -10.83M | -9.82M | -6.67M | -3.54M | 4.14M | 1.55M | -123.54K | 19.28M | 19.61M | 22.83M | 37.55M | 23.72M | 23.35M | 15.73M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 570.88K | 1.31M | 502.64K | 369.42K | 473.14K | 28.65K | 69.12K | 27.58K | 117.6K | 515.33K | 50.87K | -80.85K | -104.42K | 14.14K | 132.8K | 314.14K | 48.61K | 324.69K | 41.76K | -93.46K | 737.85K |
Operating Cash Flow | -11.82M | -10.79M | -10.72M | -9.52M | -8.69M | -8.23M | -7.66M | -7.14M | -6.55M | -6.62M | -6.42M | -6.69M | -6.66M | -5.87M | -5.44M | -4.62M | -4.11M | -3.33M | -2.76M | -2.65M | -2.33M |
Capital Expenditures | -79.68K | -116.08K | -48.84K | -107.3K | -142.59K | -106.19K | -163.78K | -117.27K | -111.02K | -171.04K | -318.6K | -282.04K | -390.67K | -440.22K | -253.3K | -277.9K | -140.23K | -30.65K | 4 | n/a | 2 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.7M | -2.68M | -5.27M | -10.23M | -11.21M | -20.89M | -35.4M | -37M | -41.02M | -31.75M | -17.76M | -10.64M | -4.57M | -3.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 9.28M | 11.69M | 13.35M | 17.31M | 19.17M | 21.51M | 34.64M | 35.25M | 37.1M | 35.36M | 18.09M | 10.98M | 4.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -175K | -10.11M | -10.11M | -10.11M | -9.93M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 7.5M | 8.9M | 8.03M | 6.97M | 7.81M | 514.53K | -917.41K | -1.88M | -4.03M | 3.44M | 13.66K | -9.87M | -10.83M | -13.48M | -10.19M | -277.91K | -140.23K | -30.66K | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 250K | 4.21M | 4.61M | 5.33M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -6.06K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -242.95K | -240.21K | -206.02K | -156.71K | -130.36K | 7.38M | 7.51M | 7.51M | 7.52M | n/a | n/a | n/a | n/a | n/a | 21.07M | 21.07M | 21.07M | 21.07M | -500K | -500K | -500K |
Financial Cash Flow | 6.2M | 2.85M | 1.81M | 1.85M | 953.56K | 7.38M | 7.59M | 9.44M | 9.87M | 2.35M | 2.27M | 411.7K | n/a | n/a | 21.07M | 21.07M | 21.07M | 21.32M | 3.71M | 4.11M | 4.83M |
Net Cash Flow | 1.88M | 963.3K | -887K | -697K | 71.71K | -336.49K | -947.43K | 468.6K | -679.39K | -792.2K | -4.14M | -16.15M | -17.49M | -19.35M | 5.44M | 16.17M | 16.82M | 17.96M | 953.72K | 1.46M | 2.5M |
Free Cash Flow | -11.9M | -10.91M | -10.77M | -9.63M | -8.83M | -8.34M | -7.82M | -7.25M | -6.67M | -6.79M | -6.73M | -6.97M | -7.05M | -6.31M | -5.7M | -4.9M | -4.25M | -3.36M | -2.76M | -2.65M | -2.33M |
Adj. Free Cash Flow | -13.5M | -14.23M | -13.82M | -12.57M | -11.63M | -11.15M | -10.46M | -11.06M | -11.63M | -13.11M | -16.11M | -17.97M | -19.66M | -18.92M | -15.25M | -14.3M | -10.55M | -6.29M | -5.75M | -2.9M | -2.8M |
Maintenance CapEx | -79.67K | -116.07K | -36.4K | -36.4K | -36.4K | n/a | -2.78K | -7.4K | -36.44K | -36.44K | -251.25K | -197.42K | -168.37K | -277.94K | -91.02K | -140.23K | -140.23K | -30.65K | 4 | n/a | 2 |
Growth CapEx | -3 | -3 | -12.44K | -70.9K | -106.19K | -106.19K | -161K | -109.87K | -74.58K | -134.6K | -67.35K | -84.63K | -222.3K | -162.28K | -162.28K | -137.67K | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -11.9M | -10.91M | -10.76M | -9.56M | -8.73M | -8.23M | -7.66M | -7.14M | -6.59M | -6.65M | -6.67M | -6.89M | -6.82M | -6.15M | -5.53M | -4.76M | -4.25M | -3.36M | -2.76M | -2.65M | -2.33M |
Add to Watchlist
Select watchlists to add or remove BRTX